Free Trial
OTCMKTS:DGNOF

DIAGNOS 11/21/2024 Earnings Report

DIAGNOS logo
$0.26 0.00 (-0.16%)
As of 03:52 PM Eastern

DIAGNOS EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

DIAGNOS Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

DIAGNOS Announcement Details

Quarter
Time
During Market Hours
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

DIAGNOS' next earnings date is estimated for Monday, October 20, 2025, based on past reporting schedules.

Conference Call Resources

DIAGNOS Earnings Headlines

DIAGNOS Announces Voting Results of Meeting of Shareholders
DIAGNOS Announces Closing of Private Placement
This dark force is about to change everything
Something unusual is unfolding inside the Republican Party — from Marjorie Taylor Greene breaking ranks to Ted Cruz calling the White House a “mafia,” and even Trump’s approval rating slipping. But veteran analyst Porter Stansberry says this isn’t really about politics at all. It’s part of a much larger shift he calls The Final Displacement — a historic economic and social realignment already impacting millions of Americans. His new documentary explains what’s driving it and how to prepare before it accelerates further.tc pixel
DIAGNOS to Extend Stock Warrants Exercise Period
See More DIAGNOS Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like DIAGNOS? Sign up for Earnings360's daily newsletter to receive timely earnings updates on DIAGNOS and other key companies, straight to your email.

About DIAGNOS

DIAGNOS (OTCMKTS:DGNOF) provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

View DIAGNOS Profile

More Earnings Resources from MarketBeat